A detailed history of Marion Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Marion Wealth Management holds 580 shares of LLY stock, worth $451,599. This represents 0.14% of its overall portfolio holdings.

Number of Shares
580
Previous 1,024 43.36%
Holding current value
$451,599
Previous $927,000 44.66%
% of portfolio
0.14%
Previous 0.27%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$772.14 - $960.02 $342,830 - $426,248
-444 Reduced 43.36%
580 $513,000
Q2 2024

Jul 09, 2024

BUY
$724.87 - $909.04 $2,899 - $3,636
4 Added 0.39%
1,024 $927,000
Q1 2024

Apr 08, 2024

BUY
$592.2 - $792.28 $60,404 - $80,812
102 Added 11.11%
1,020 $793,000
Q4 2023

Jan 10, 2024

BUY
$525.19 - $619.13 $482,124 - $568,361
918 New
918 $535,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Marion Wealth Management Portfolio

Follow Marion Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marion Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Marion Wealth Management with notifications on news.